5 January 2022 in Progress in Neuro-Psychopharmacology and Biological Psychiatry
13 May 2014 in Psychopharmacology
26 July 2020 in VCOT Open
Objective This study aimed to report the adverse drug events and treatment outcome of systemic linezolid therapy to manage multi-drug resistant orthopaedic surgical site infection in dogs. Materials and Methods Retrospective case review of four dogs that received linezolid to treat surgical site infections after orthopaedic surgery. Reevaluations consisted of a clinical examination or a telephone interview. Results Serum drug concentrations varied. All dogs showed a temporary resolution of clinical signs of surgical site infection. Two dogs that received linezolid at the previously reported dose developed drug-associated side effects. The side effects were anorexia, nausea, vomiting and regenerative anaemia. All side effects resolved after the discontinuation of linezolid. Surgical site infection recurred in two dogs 52 and 177 days after discontinuing linezolid respectively. Clinical significance Adverse drug events occurred in dogs receiving oral linezolid at the dosage of 10 to 20 mg/kg. Oral linezolid therapy failed to resolve deep orthopaedic surgical site infections in two out of four dogs. As a tertiary antimicrobial, linezolid should only be used in carefully selected cases while monitoring for drug-associated side effects. P.-Y.C., D.J.M.-L., and R.A.H.-B., contributed to case management and follow-up interview or examination. J.Y. contributed to data collection. P.-Y.C. and D.J.M.-L. contributed to manuscript preparation. R.H.-B. contributed to manuscript revision. * J.Y.’s current workplace is VCA West Coast Specialty and Emergency Animal Hospital, Orange County, California, United States. R.A.H-B’s current workplace is the Sam’s Clinic, Marin, California, United States. Received: 19 February 2020 Accepted: 08 June 2020 Publication Date: 05 August 2020 (online) © . Georg Thieme Verlag KG Stuttgart · New York
7 June 2021 in Veterinary Record Case Reports
A 7‐year‐old, intact female, Siberian Husky was presented for a vulvovaginal tumour noted 6 months prior to presentation. The tumour had doubled with each oestrus cycle. Haematology and serum biochemistry, thoracic and abdominal imaging were unremarkable. The cytology of the tumour was most consistent with a lipoma. Due to increasing size and discomfort from the tumour, excision and ovariohysterectomy were elected by the owner. Histopathology revealed a lipoma with no smooth muscle. Immunohistochemical labelling for oestrogen receptors revealed strong nuclear expression in adipocytes within the tumour. Immunohistochemical labelling for progesterone receptors was negative. Based on these findings, the tumour was diagnosed as an oestrogen responsive lipoma. One‐year post surgery, the patient is doing well with no recurrence of the tumour noted on physical examination. In addition to hormone responsive smooth muscle tumours, hormone responsive lipomas should be considered as a differential diagnosis for tumours in the reproductive tract that grows during oestrus cycles.
13 March 2026 in American Journal of Veterinary Research
Objective: To investigate the safety and complication rate of 2 vessel-sealing devices (VSDs) used for hepatic surgery in dogs. Methods: This was a retrospective study from 6 institutions from January 2012 through June 2024 including dogs that underwent a complete or partial liver lobectomy or a liver biopsy using a VSD as the sole method. Surgical complications based on the type of liver lobectomy, severity of complication, type of VSD used, mass size, and liver lobe location were reported as the percentage of dogs experiencing the event of interest. Group differences were compared using a 2-tailed Fisher exact or χ 2 test. Maximal tumor diameter in relation to complication type was assessed using a Kruskal-Wallis test. Statistical significance was set at P = .05. Results: 58 dogs were included in the study. For liver lobectomy cases, complications occurred in 42 of 48 dogs and were mostly minor. No differences in complications were noted based on liver mass size, liver lobe location, type of liver lobectomy performed, severity of complication, or type of VSD used. Intra- or postoperatively, biliary leakage occurred in 4 of 48 dogs. The complication rate for dogs undergoing a liver biopsy was 5 of 10 and consisted of minor bleeding in 90% of the cases. Conclusions: Despite the high incidence of minor complications, VSD can be safely used for hepatic surgery in dogs. The ability of the 2 VSDs used to seal bile ducts when a liver lobectomy is performed requires further investigation. Clinical Relevance: VSDs can be considered an alternative method for performing liver lobectomies in dogs.